The prolonged effect of using hormonal contraception in female patients with ischemic stroke in developing countries


Background: Hormonal contraception is a common method used by the FP receiver in Indonesia. Usually, hormonal contraception contains progestins and/or in combination with estrogens. Estrogens known has a potential of complication such as the development of thromboembolism thereby increasing the risk of developing ischemic stroke. While in other studies, the impact of progesterone contraception on cardiovascular disease cannot yet be explained. 
Objective: This study aims to determine the characteristics of hormonal contraceptive users in ischemic stroke patients.
Method: This study used a descriptive observational study with a successive sampling of all stroke ischemic patients with a history of hormonal contraceptive users. Research variables include age, occupation, medical records, type and duration of hormonal contraceptive use, also the time that a stroke has struck after stopping contraception. Univariate or descriptive analysis is applied to the frequency distribution of this variable
Results: The highest age group was obtained from the ‘Middle Age Begins’ Patients (46-55 years) (40%) as many as 42% of respondents worked as housewives. About 40% of respondents have suffered from hypertension and also 50% have a history of hereditary hypertension. 54% of respondents used hormonal contraception for more than 5 years with the most frequent type of hormonal contraception being injection only progestin (42%) 68. stroke episodes that appear at the age of fewer than 12 years after the termination of hormonal contraception.
Conclusion: the characteristics of hormonal contraceptive users in ischemic stroke patients as follows: the majority of the age group is ‘Middle Age Begins’ (46-55 years) with most of them working as housewives, with a history of hypertension, most sufferers of hereditary disease, the highest proportion used hormonal contraception more than 5 years with most types of use injected with progesterone only, and the average respondent stopped using hormonal contraception at a low of 12 years before the occurrence of ischemic stroke.


  • Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group. (2003). Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney international, 63(1), 225-232.
  • Carlton, C., Banks, M., & Sundararajan, S. (2018). Oral contraceptives and ischemic stroke risk. Stroke, 49(4), e157-e159.
  • Dewata, L., Prasetyo, B., Yuliati, A., & Wahyuhadi, J. (2017). Hormonal Contraceptive Exposure and Risk Factors for Meningioma in Soetomo Hospital 2012–2016. Advanced Science Letters, 23(4), 3291-3294.
  • do Carmo Souza, R., Borges, G. F., & Mourão, D. M. (2018). Contracepção oral e fatores de risco em mulheres brasileiras: revisão integrativa. Academus Revista Científica da Saúde, 3(1), 92-105.
  • Ea, O., Ajani, E. N., & Nenna, M. G. (2015). Constraints to Brood and Sell Poultry Production among Farmers in Enugu State, Nigeria. Current Research in Agricultural Sciences, 2(2), 73-80.
  • Faubion, S. S., Casey, P. M., & Shuster, L. T. (2012). Hormonal contraception and migraine: clinical considerations. Current pain and headache reports, 16(5), 461-466.
  • Hussain, S. F. (2004). Progestogen-only pills and high blood pressure: is there an association?: A literature review. Contraception, 69(2), 89-97.
  • Idris, I., Thomson, G. A., & Sharma, J. C. (2006). Diabetes mellitus and stroke. International journal of clinical practice, 60(1), 48-56.
  • Jusuf, M. I., Machfoed, M. H., & Keman, S. (2016). Infarction Stroke Risk Prediction Model for Indonesian Population: A Case-Control Study. Bangladesh Journal of Medical Science, 15(2), 269-274.
  • Kasner, S. E., Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., ... & Sila, C. A. (2006). Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation, 113(4), 555-563.
  • Kemmeren, J. M., Tanis, B. C., van den Bosch, M. A., Bollen, E. L., Helmerhorst, F. M., van der Graaf, Y., ... & Algra, A. (2002). Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke, 33(5), 1202-1208.
  • Lestari, S. W, Khairunissa , S.T, Midoen, Y.H, Hestiantoro, A., Tanojo, T.D, Itishom, R. (2019).An update of Male contraception: A review of cellular perspective. J Glob Pharma Technol. 11(1):219–30.
  • Mir, D., Ardabilygazir, A., Afshariyamchlou, S., & Sachmechi, I. (2018). Malignant Hypertension in Association with Low Estrogen Dose Oral Contraceptives: Case Report and Review of Literature. Cureus, 10(7).
  • Roach, R. E., Helmerhorst, F. M., Lijfering, W. M., Stijnen, T., Algra, A., & Dekkers, O. M. (2015). Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database of Systematic Reviews, (8).
  • Røttingen, J. A., Regmi, S., Eide, M., Young, A. J., Viergever, R. F., Årdal, C., ... & Terry, R. F. (2013). Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?. The Lancet, 382(9900), 1286-1307.
  • Sacco, S., Merki-Feld, G. S., Ægidius, K. L., Bitzer, J., Canonico, M., Kurth, T., ... & Mitsikostas, D. D. (2017). Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). The journal of headache and pain, 18(1), 108.
  • Saifudin, A. B., Afandi, B., Baharudin, M., & Soekir, S. (2008). Practical Handbook on Contraception Services. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo.
  • Smith Jr, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., ... & Lloyd-Jones, D. M. (2011). AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation, 124(22), 2458-2473.
  • Triyanto, E. (2014). Pelayanan keperawatan bagi penderita hipertensi secara terpadu. Yogyakarta: Graha Ilmu.
  • YI, P. N., & Primadi, A. (2020). Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers. Journal of Basic and Clinical Physiology and Pharmacology, 30(6).
  • Zaenurrohmah, D. H., & Rachmayanti, R. D. (2017). Relationship Between Knowledge and Hypertension History with Blood Pressure Control in Elderly. Jurnal Berkala Epidemiologi, 5(2), 174-184.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.